Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

4.24
BATS BZX Real-Time Price
As of 9:50am ET
 +0.03 / +0.71%
Today’s Change
1.50
Today|||52-Week Range
5.05
+38.11%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close4.21
Today’s open4.25
Day’s range4.20 - 4.28
Volume3,614
Average volume (3 months)1,053,417
Market cap$399.1M
Dividend yield--
Data as of 9:50am ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)-8.82%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARAYAccuray Inc+0.08+1.50%
ENTLEntellus Medical Inc+0.07+0.39%
HTWRHeartWare Internatio...+0.68+2.39%
NVDQNovadaq Technologies...0.000.00%
Data as of 9:50am ET, 05/24/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs